期刊文献+

恶性大脑中动脉梗死的预测和重症监护治疗 被引量:4

Prediction and intensive care of malignant middle cerebral artery infarction
原文传递
导出
摘要 恶性大脑中动脉梗死(malignant middle cerebral artery infarction,mMCAI)患者在重症监护室内接受保守治疗时的病死率高达41%~78%,恶性脑水肿引起的小脑幕切迹疝形成是导致患者死亡的最常见原因。一些证据支持偏侧颅骨切除术用于mMCAI患者的治疗。在做出手术治疗决策之前,必须对患者进行支持性和辅助性治疗,因此,mMCAI的预测和重症监护治疗具有十分重要的意义。文章对mMCAI的预测因素和重症监护治疗进行了综述。 Mortality of patients with malignant middle cerebral artery infarction (mMCAI) is as high as 41% to 78% with the conservative treatment in the intensive care unit. Malignant edema caused tentorial herniation is the most common cause of resulting in the death of patients. Some evidence supports the hemicraniectomy for the treatment of patients with mMCAI. The patients must receive supportive and adjuvant therapies before surgical decision making. Therefore, the prediction and intensive care of mMCAI have a very important significance. This article reviews the predictive factors and intensive care of mMCAI.
出处 《国际脑血管病杂志》 北大核心 2014年第12期930-933,共4页 International Journal of Cerebrovascular Diseases
关键词 梗死 大脑中动脉 卒中 脑缺血 脑水肿 重症监护 Infarction, Middle Cerebral Artery Stroke Brain Iscehmia Brain Edema Intensive Care
  • 相关文献

参考文献43

  • 1Arch AE, Sheth KN. Malignant cerebral edema after large anterior circulation infarction: a review. Curr Treat Options Cardiovasc Med, 2014, 16: 275.
  • 2Hacke W, Schwab S, Horn M, et al. 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol, 1996, 53: 309-315.
  • 3Wartenberg KE. Malignant middle cerebral artery infarction. Curr Opin Crit Care, 2012, 18: 152-163.
  • 4Moulin DE, Lo R, Chiang J, et al. Prognosis in middle cerebral artery occlusion. Stroke, 1985, 16: 282-284.
  • 5Simard JM, Kent TA, Chen M, et al. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol, 2007, 6: 258-268.
  • 6Ng LK, Nimmannitya J. Massive cerebral infarction with severe brain swelling: a clirlicopathological study. Stroke, 1970, 1: 158- 163.
  • 7Jaramillo A, Gongora-Rivera F, Labreuche J, et al. Predictors for malignant middle cerebral artery infarctions: a postmortem analysis. Neurology, 2006, 66: 815-820.
  • 8Hofmeijer J, Kappelle LJ, Algra A, et al; HAMLET investigators. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [ HAMLET ] ): a multicentre, open, randomised trial. Lancet Neurol, 2009, 8: 326-333.
  • 9Juttler E, Schwab S, Schmiedek P, et al; DESTINY Study Group. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke, 2007, 38: 2518-2525.
  • 10Vahedi K, Vicaut E, Mateo J, et al; DECIMAL Investigators. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke, 2007, 38: 2506-2517.

二级参考文献192

  • 1Simard JM,Kent TA,Chen M,et al.Brain oedema in focal ischaemia:molecular pathophysiology and theoretical implications.Lancet Neurol,2007,6:258-268.
  • 2Ropper AH,Shafran B.Brain edema after stroke:clinical syndrome and intracranial pressure.Arch Neurol,1984,41:26-29.
  • 3Schwab S,Aschoff A,Spranger M,et al.The value of intracranial pressure monitoring in acute hemispheric stroke.Neurology,1996,47:393-398.
  • 4Hacke W,Schwab S,Horn M,et al."Malignant" middle cerebral artery territory infarction:clinical course and prognostic signs.Arch Neurol,1996,53:309-315.
  • 5Wijdicks EF,Diringer MN.Middle cerebral artery territory infarction and early brain swelling:progression and effect of age on outcome.Mayo Clin Proc,1998,73:829-836.
  • 6Simard JM,Sahuquillo J,Sheth KN,et al.Managing malignant cerebral infarction.Curr Treat Options Neurol,2011,13:217-229.
  • 7Walcott BP,Kuklina EV,Nahed BV,et al.Craniectomy for malignant cerebral infarction:prevalence and outcomes in US hospitals.PLoS One,2011,6:e29193.
  • 8Cho DY,Chen TC,Lee HC.Ultra-early decompressive craniectomy for malignant middle cerebral artery infarction.Surg Neurol,2003,60:227-232.
  • 9Foerch C,Otto B,Singer OC,et al.Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion.Stroke,2004,35:2160-2164.
  • 10Haring HP,Dilitz E,Pallua A,et al.Attenuated corticomedullary contrast:an early cerebral computed tomography sign indicating malignant middle cerebral artery infarction:a case-control study.Stroke,1999,30:1076-1082.

共引文献13

同被引文献72

  • 1Khanna A, Walcott BP, Kahle KT, et al. Effect of gh'benclamide on the prevention of secondary brain injury following ischemic stroke in humans [ J]. Neurosurg Focus, 2014, 36(1): E11.
  • 2Berrouschot J, Sterker M, Bettin S, et al. Mortality of space- occupying (‘malignant') middle cerebral artery infarction under conservative intensive care [ J ]. Intensive Care Med, 1998, 24: 620-623.
  • 3Hacke W, Schwab S, Horn M, et al. 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs [ J]. Arch Neurol, 1996, 53: 309-315.
  • 4Jickling GC, Liu D, Stamova B, et al. Hmorrhagic transformation after ischemic stroke in animals and humans [ J ]. J Cereb Blood Flow Metab, 2014, 34: 185-199.
  • 5Rothstein L, Jickling GC. Ischemic stroke biomarkers in blood [ J]. Biomark Med, 2013, 7: 37-47.
  • 6Brogan ME, Manno EM. Treatment of malignant brain edema and increased intracranial pressure after stroke [ J ]. Curr Treat Options Neurol, 2015, 17: 327.
  • 7Marble A. Glibenclamide, a new sulphonylurea: whither oral hypoglyc aemic agents [ J ] ? Drugs, 1971, 1 : 109 -115.
  • 8Kunte H, Schmidt S, Eliasziw M, et al. Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke[ J]. Stroke, 2007, 38: 2526-2530.
  • 9Kunte H, Busch MA, Trostdorf K, et al. Hmaorrhagic transformation of ischemic stroke in diabetics on sulfonylureas [ J ]. Ann Neurol, 2012, 72: 799-806.
  • 10Kimberly WT, Battey TW, Pham L, et al. Glyburide is associated with attenuated vasogenic edema in stroke patients [ J ]. Neurocrit Care, 2014, 20: 193-201.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部